Conatus Pharmaceutical: Act II In Fighting Liver Disease

One of the newest small cap biotechs that I’ve added to the Small Cap Gems portfolio is Conatus Pharmaceuticals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.